Sinus Bradycardia in Habitual Cocaine Users.
Common physiological manifestations of cocaine are related to its adrenergic effects, due to inhibition of dopamine and norepinephrine uptake at the postsynaptic terminal. Few studies have documented bradycardia secondary to cocaine use, representing the antithesis of its adrenergic effects. We assessed the prevalence of sinus bradycardia (SB) in habitual cocaine users and postulated a mechanism for this effect. One hundred sixty-two patients with a history of cocaine use were analyzed and compared with age- and gender-matched controls. SB was defined as a rate of <60 beats/min and habitual cocaine use as 2 or more documented uses >30 days apart. Propensity score-matching analysis was applied to balance covariates between cocaine users and nonusers and reduce selection bias. Patients with a history of bradycardia, hypothyroidism, or concomitant beta-blocker use were excluded. Mean age of study patients was 44 ± 8 years. SB was observed in 43 of 162 (27%) cocaine users and in 9 of 149 (6%) nonusers (p = 0.0001). Propensity score-matching analysis matched 218 patients from both groups. Among matched patients SB was observed in 25 of 109 (23%) cocaine users and in 5 of 109 (5%) nonusers (p = 0.0001). Habitual cocaine use was an independent predictor of SB and associated with a sevenfold increase in the risk of SB (95% CI 2.52 to 19.74, p = 0.0002). In conclusion, habitual cocaine use is a strong predictor of SB and was unrelated to recency of use. A potential mechanism for SB may be related to cocaine-induced desensitization of the beta-adrenergic receptor secondary to continuous exposure. Symptomatic SB was not observed; thus, pacemaker therapy was not indicated.
Electrophysiology Section, Division of Cardiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
Sona M
SM
Franklin
Department of Medicine, Ochsner Health System, New Orleans, Louisiana.
Sudarone
S
Thihalolipavan
Electrophysiology Section, Division of Cardiology, Drexel University College of Medicine, Philadelphia, Pennsylvania. Electronic address: john.fontaine@drexelmed.edu.
John M
JM
Fontaine
D000328:Adult; D001146:Arrhythmia, Sinus / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D001919:Bradycardia / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D003042:Cocaine / Q000009:adverse effects*; D019970:Cocaine-Related Disorders / Q000150:complications* / Q000453:epidemiology; D018765:Dopamine Uptake Inhibitors / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D015994:Incidence; D008297:Male; D015995:Prevalence; D057216:Propensity Score; D012189:Retrospective Studies; D014481:United States / Q000453:epidemiology
D018765:Dopamine Uptake Inhibitors; D003042:Cocaine